This poster presented at AACR 2022, describes how our multi-omics platform can identify and analyze biological signals for pancreatic cancer, and enable the development of liquid biopsy tests for the early detection of pancreatic cancer. Our platform detects proteomic, metabolomic, and lipidomic signatures from blood that show statistically significant differences between cancer and controls that are both known and unknown to be associated with pancreatic cancer.
Download Poster
